BTIG Sticks to Its Buy Rating for Vapotherm Inc (VAPO)


In a report released yesterday, Sean Lavin from BTIG maintained a Buy rating on Vapotherm Inc (VAPO), with a price target of $26. The company’s shares closed yesterday at $19.85.

Lavin observed:

“Vapotherm got off to a good start with a solid Q4 report, including revenue slightly above the 800 bps y/y step up in gross margin. $49-$51M bracketed the Street and the gross margin outlook of 41.0-41.5% was set just above our model. While anticipated 2019 operating spend of $64-$66M was set higher than we and consensus were modeling, this is largely due to higher stock-based comp. This was a clean first report as a public company. We view the sales outlook as achievable and would not be surprised by minor beats throughout 2019.”

According to TipRanks.com, Lavin is a 5-star analyst with an average return of 10.3% and a 59.8% success rate. Lavin covers the Healthcare sector, focusing on stocks such as Establishment Labs Holdings Inc, Helius Medical Technologies, and Tactile Systems Technology.

Vapotherm Inc has an analyst consensus of Moderate Buy, with a price target consensus of $27, which is a 36.0% upside from current levels. In a report released today, Canaccord Genuity also maintained a Buy rating on the stock with a $27 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $22.07 and a one-year low of $14.70. Currently, Vapotherm Inc has an average volume of 59.88K.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Vapotherm, Inc. is a medical technology company, which engages in the development and commercialization of medical devices for patients suffering from respiratory distress. It offers Hi-VNI Technology, a product which delivers noninvasive ventilator support by providing heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. The company was founded William F. Niland, Jun Cortez, and William Cirksena in 1998 and is headquartered in Exeter, NH.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts